| CTLA-4: From mechanism to autoimmune therapy A Hosseini, T Gharibi, F Marofi, Z Babaloo, B Baradaran International immunopharmacology 80, 106221, 2020 | 172 | 2020 |
| Effects of photodynamic therapy on clinical and gingival crevicular fluid inflammatory biomarkers in chronic periodontitis: A split‐mouth randomized clinical trial R Pourabbas, A Kashefimehr, N Rahmanpour, Z Babaloo, A Kishen, ... Journal of periodontology 85 (9), 1222-1229, 2014 | 109 | 2014 |
| The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: interleukin-17A and interleukin-17F serum levels Z Babaloo, MR Aliparasti, F Babaiea, S Almasi, B Baradaran, M Farhoudi Immunology letters 164 (2), 76-80, 2015 | 103 | 2015 |
| Biological effects of IL-21 on different immune cells and its role in autoimmune diseases T Gharibi, J Majidi, T Kazemi, R Dehghanzadeh, M Motallebnezhad, ... Immunobiology 221 (2), 357-367, 2016 | 94 | 2016 |
| Peripheral Th17/Treg imbalance in elderly patients with ischemic stroke S Dolati, M Ahmadi, M Khalili, AA Taheraghdam, H Siahmansouri, ... Neurological Sciences 39, 647-654, 2018 | 87 | 2018 |
| The role of gut microbiota and IL-23/IL-17 pathway in ankylosing spondylitis immunopathogenesis: New insights and updates F Babaie, M Hasankhani, H Mohammadi, E Safarzadeh, A Rezaiemanesh, ... Immunology letters 196, 52-62, 2018 | 85 | 2018 |
| Nanocurcumin restores aberrant miRNA expression profile in multiple sclerosis, randomized, double‐blind, placebo‐controlled trial S Dolati, L Aghebati‐Maleki, M Ahmadi, F Marofi, Z Babaloo, H Ayramloo, ... Journal of cellular physiology 233 (7), 5222-5230, 2018 | 84 | 2018 |
| Multiple sclerosis: Therapeutic applications of advancing drug delivery systems S Dolati, Z Babaloo, F Jadidi-Niaragh, H Ayromlou, S Sadreddini, ... Biomedicine & Pharmacotherapy 86, 343-353, 2017 | 82 | 2017 |
| Targeting STAT3 in cancer and autoimmune diseases T Gharibi, Z Babaloo, A Hosseini, M Abdollahpour-Alitappeh, V Hashemi, ... European journal of pharmacology 878, 173107, 2020 | 80 | 2020 |
| Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis S Dolati, Z Babaloo, H Ayromlou, M Ahmadi, R Rikhtegar, ... Journal of neuroimmunology 327, 15-21, 2019 | 78 | 2019 |
| Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases A Hosseini, T Gharibi, F Marofi, M Javadian, Z Babaloo, B Baradaran Journal of Cellular Physiology 235 (9), 5903-5924, 2020 | 77 | 2020 |
| Chrysin-nanoencapsulated PLGA-PEG for macrophage repolarization: Possible application in tissue regeneration A Firouzi-Amandi, M Dadashpour, M Nouri, N Zarghami, H Serati-Nouri, ... Biomedicine & Pharmacotherapy 105, 773-780, 2018 | 75 | 2018 |
| Interleukin-13 as an important cytokine: A review on its roles in some human diseases N Seyfizadeh, N Seyfizadeh, T Gharibi, Z Babaloo Acta microbiologica et immunologica Hungarica 62 (4), 341-378, 2015 | 74 | 2015 |
| Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet’s disease M Ahmadi, M Yousefi, S Abbaspour‐Aghdam, S Dolati, L Aghebati-Maleki, ... Journal of cellular physiology 234 (4), 3985-3994, 2019 | 71 | 2019 |
| Effects of HMGA2 siRNA and doxorubicin dual delivery by chitosan nanoparticles on cytotoxicity and gene expression of HT-29 colorectal cancer cell line H Siahmansouri, MH Somi, Z Babaloo, B Baradaran, F Jadidi-Niaragh, ... Journal of Pharmacy and Pharmacology 68 (9), 1119-1130, 2016 | 70 | 2016 |
| Interleukin-13 in Iranian patients with visceral leishmaniasis: relationship to other Th2 and Th1 cytokines Z Babaloo, PM Kaye, MB Eslami Transactions of the Royal Society of Tropical Medicine and Hygiene 95 (1), 85-88, 2001 | 66 | 2001 |
| Changes in Th17 cells function after nanocurcumin use to treat multiple sclerosis S Dolati, M Ahmadi, R Rikhtegar, Z Babaloo, H Ayromlou, ... International immunopharmacology 61, 74-81, 2018 | 62 | 2018 |
| Dysregulated network of miRNAs involved in the pathogenesis of multiple sclerosis S Dolati, F Marofi, Z Babaloo, L Aghebati-Maleki, L Roshangar, M Ahmadi, ... Biomedicine & Pharmacotherapy 104, 280-290, 2018 | 53 | 2018 |
| mTOR Signaling pathway as a master regulator of memory CD8+ T‐cells, Th17, and NK cells development and their functional properties D Rostamzadeh, M Yousefi, MR Haghshenas, M Ahmadi, S Dolati, ... Journal of Cellular Physiology 234 (8), 12353-12368, 2019 | 51 | 2019 |
| Increased IL-17A but decreased IL-27 serum levels in patients with multiple sclerosis Z Babaloo, R Khajir Yeganeh, M Farhoodi, B Baradaran, M Bonyadi, ... Iranian Journal of Immunology 10 (1), 47-54, 2013 | 48 | 2013 |
